Concepedia

Mark Nuijten

MN

Statistics

Publications

46

Citations

1.8K

H-Index

25

Active since

1995

Affiliations

Erasmus University Rotterdam(Current)

Netherlands Leprosy Relief

Danone (France)

Abbott (Germany)

Shell (Netherlands)

Mark Nuijten is an author at Erasmus University Rotterdam specializing in medicine, health economics, and economic evaluation.

ORCID

Top concepts

Publications per year

1995–2022

46

Publications

46

The economic costs of disease related malnutrition

Karen Freijer, Siok Swan Tan, Marc Koopmanschap et al. · Clinical Nutrition · 2012 · 224 citations · Full text

, , +5

Cost Effectiveness of Palivizumab for Respiratory Syncytial Virus Prophylaxis in High-Risk Children

Mark Nuijten, W Wittenberg, M. Lebmeier · PharmacoEconomics · 2007 · 99 citations

, , +7

Importance of nondrug costs of intravenous antibiotic therapy

Arthur R. H. van Zanten, Peter Engelfriet, Karin van Dillen et al. · Critical Care · 2003 · 79 citations · Full text

Primary prevention of nephrolithiasis is cost‐effective for a national healthcare system

Yair Lotan, Inmaculada Buendía Jiménez, Irene Lenoir‐Wijnkoop et al. · British Journal of Urology · 2012 · 78 citations

Pricing Zolgensma – the world’s most expensive drug

Mark Nuijten · Journal of Market Access & Health Policy · 2021 · 75 citations · Full text

, , +6

1–5 of 46